The biggest news at the Department of Health and Human Services this week is the sweeping impact of the federal government shutdown beginning October first. As a result, HHS has furloughed tens of thousands of workers and halted or delayed vital functions in agencies like the FDA, CDC, CMS, and NIH. That means drug approvals and public health responses are paused, research grants are delayed, and, for providers, Medicare claim payments are on hold. For patients, the most immediate impact is that many telehealth services are no longer being reimbursed under Medicare, rolling back pandemic-era flexibilities except for some behavioral health care. Providers are now being asked to issue Advance Notices of Beneficiary Noncoverage to their patients, warning that telehealth visits might not be covered.
In parallel, HHS is in the midst of a major reorganization, following an executive order from President Trump earlier this year. Secretary Robert F. Kennedy, Jr. announced that HHS has begun merging agencies into a new body called the Administration for a Healthy America, and the CDC will pivot its focus toward infectious diseases. This reorganization is expected to cut the HHS workforce by nearly 20%, with the NIH, FDA, and CDC seeing the deepest reductions. According to HHS, these moves are projected to save taxpayers nearly $2 billion a year. Secretary Kennedy called this “a necessary modernization to deliver more efficient, targeted public health.”
The shutdown and reorganization are already creating ripples for Americans, especially those relying on federal programs, as well as healthcare providers, life sciences companies, and local governments who depend on timely funding and regulatory clarity. Businesses face uncertainty about Medicaid and Medicare policies as the Senate prepares to vote on new spending priorities that could reshape federal healthcare spending.
Meanwhile, HHS just released major changes to its Grants Policy Statement with new requirements for civil rights assurances, earlier deadlines for no-cost grant extensions, and a lower threshold for when budget revisions require HHS approval. Grantees will need to request no-cost extensions sooner—at least ten days prior to a project’s end—while even a 10% change in total budget now triggers a review. According to HHS, these updates are meant to enforce accountability and compliance as federal oversight evolves.
On the regulatory front, HHS has ramped up enforcement on health information sharing, prioritizing action against “information blocking.” Over 1,300 reports of information blocking have been submitted, and HHS signals penalties will be forthcoming. This will require health IT developers, exchanges, and healthcare providers to ensure medical data can flow when legally permitted.
For listeners wondering what’s next, stay tuned for updates on the government funding situation and details on how HHS’s reorganization plans will affect specific programs. If you’re a provider or grantee, check HHS’s website and your professional associations for the latest guidance—and consider joining upcoming webinars like Feldesman’s session on new grants policy changes. If you rely on Medicare or receive care from federally-supported clinics, reach out to your provider for how these changes might impact your access or costs.
Thanks for tuning in, and don’t forget to subscribe. This has been a Quiet Please production, for more check out quietplease dot ai.
For more
http://www.quietplease.aiGet the best deals
https://amzn.to/3ODvOtaThis content was created in partnership and with the help of Artificial Intelligence AI